drugset / Trial / NCT07382544
Phase 1b Trial of BMS-986504 in Combination With Olaparib in Patients With MTAP Loss
RandomizedParallel-groupOpen-labelTreatment
Summary
The goal of this clinical research study is to learn about the safety and effects of BMS-986504 in combination with olaparib in patients with advanced solid tumors with MTAP loss.
Timeline
- Start
- 2026-02-12
- Primary completion
- 2030-01-31
- Completion
- 2032-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MRTX1719 | Unknown | — | Oral |
| Subject | Olaparib | Small molecule | — | Oral |